Skip to main content
. 2020 Aug 29;43(6):1147–1159. doi: 10.1007/s13402-020-00548-y

Fig. 4.

Fig. 4

SPTBN1, KHSRP and PYGL as prognostic markers for resected pancreatic cancer patients. a. Immunohistochemistry validation of SPTBN1, KHSRP and PYGL on TMAs of 82 patients. b. Kaplan-Meier curves for SPTBN1, KHSRP and PYGL with p values 0.0034, 0.0059 and 0.016, respectively. c. Immunofluorescence of KHSRP (red) and SPTBN1 (green) in Hs766t cells